The Business of Treating Rare Diseases: An Interview with Alex Sapir


On this episode of The Henna Hundal Show, Henna Hundal interviews Alex Sapir, President and CEO of Dova Pharmaceuticals. With a background in economics and business, Mr. Sapir has steered various biotechnology and healthcare companies towards increased product output and revenue generation. In this interview, Mr. Sapir discusses the business of running a clinical-stage pharmaceutical company devoted to addressing orphan diseases, which are characterized by the U.S. Food and Drug Administration as diseases afflicting under 200,000 individuals across the country.